ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Antiviral agent: Treatment of hepatitis C
NS5B RNA dependent RNA polymerase inhibitor
- Dasabuvirum (Latin)
- Dasabuvir (German)
- Dasabuvir (French)
- Dasabuvir (Spanish)
- Dasabuvir (OS: USAN)
- ABT-333 (IS)
- UNII-DE54EQW8T1 (IS)
- Sodium Monohydrate (OS: ChemID)
- ABT-333 sodium monihydrate (IS)
AbbVie, Croatia (Hrvatska); AbbVie, Slovenia; AbbVie Deutschland, Bosnia & Herzegowina; AbbVie Polska, Poland; AbbVie S.r.L., Slovakia; AbbVie, Switzerland; AbbVie, Germany; AbbVie, France; AbbVie, United Kingdom; AbbVie, Ireland
- Viekira Pak (Dasabuvir and Ombitasvir, + Paritaprevir, + Ritonavir)
AbbVie, United States
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
|WHO||World Health Organization|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.